Medication info
Glafomin M Tablet 1/500 mg

Glafomin M Tablet 1/500 mg

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tabletGlimepiride›1mg / 1 tablet
Manufacturer / importer
Yuhan Corporation
Appearance
Light pink oblong film-coated tablet
Packaging
30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 201107227 · Approved 2011.09.27 · Insurance code 642104100

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Administer this medicine 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted taking into account the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and it was gradually increased based on blood glucose monitoring results, with doses up to glimepiride/metformin hydrochloride 8mg/2000mg having been administered. Glimepiride as a single agent generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage regimen of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next scheduled administration.

Ingredients

Manufacturer
Yuhan Corporation

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used as an adjunct to diet and exercise to help control blood sugar in patients with type 2 diabetes. Glymepride and Metformin work together to effectively lower and control blood sugar levels. It is suitable for patients who require blood sugar control and improves blood sugar management with consistent use.

How to take

Adult dose

Administer this medicine 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted taking into account the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and it was gradually increased based on blood glucose monitoring results, with doses up to glimepiride/metformin hydrochloride 8mg/2000mg having been administered. Glimepiride as a single agent generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage regimen of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next scheduled administration.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia, so it should be temporarily discontinued and discussed with a doctor in cases of rapidly declining kidney function or dehydration symptoms. This medication should not be used in patients with a kidney function below 45 mL/min/1.73 m², and elderly patients or those taking medications that affect kidney function should have their kidney function regularly monitored. As it may increase the risk of cardiovascular disease, cardiovascular status should be carefully monitored while taking this medication. This medication should not be given to patients with insulin-dependent diabetes, acute metabolic acidosis, severe liver dysfunction, pregnant or breastfeeding women, and certain renal impairments. Patients at high risk for hypoglycemia, those with poor nutritional status or irregular eating habits, and those consuming excessive alcohol should use this medication with special caution. Adverse reactions such as gastrointestinal disturbances, allergic reactions, blood abnormalities, or vitamin B12 deficiency may occur while taking this medication, so symptoms should be reported to a doctor or pharmacist immediately. This medication may interact with other drugs, so healthcare providers must be informed of any concomitant medications, especially those that affect kidney function. Pregnant or breastfeeding women should not take this medication, and switching to insulin therapy is recommended if necessary. When administering to children or the elderly, careful observation and dose adjustments are necessary. Regular monitoring of blood glucose levels is required, and medical staff should be informed immediately of symptoms of hypoglycemia or lactic acidosis. Caution is needed while driving or operating machinery, and it should be stored out of reach of children.

Side effects

  • Lactic acidosis
  • hypoglycemia
  • diarrhea
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • dyspepsia
  • constipation
  • abdominal pain
Show 80 more
  • metallic taste
  • visual impairment
  • taste disorder
  • erythema
  • pruritus
  • urticaria
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • erythropenia
  • agranulocytosis
  • pancytopenia
  • peripheral neuropathy
  • vitamin B12 deficiency
  • increased liver enzymes
  • liver function damage
  • cholestasis
  • jaundice
  • hepatitis
  • allergic vasculitis
  • photosensitivity
  • decreased serum sodium concentration
  • hypothyroidism
  • magnesium deficiency during diarrhea
  • encephalopathy
  • hair loss
  • weight gain
  • abdominal pain
  • abdominal distension
  • vomiting
  • dyspepsia
  • palpitations
  • dizziness
  • diarrhea
  • nausea
  • leg edema
  • cardiac arrest
  • rectal carcinoma
  • vertigo
  • liver dysfunction
  • arthralgia
  • facial edema
  • erectile dysfunction
  • facial flushing
  • gastritis
  • headache
  • severe hunger
  • fatigue
  • sleep
  • weakness
  • drowsiness
  • sleep disturbances
  • instability
  • aggression
  • attention deficit
  • inattention
  • abnormal reactions
  • depression
  • confusion
  • dysphasia
  • aphasia
  • tremors
  • paralysis
  • sensory disturbance
  • dizziness
  • inability to self-regulate
  • delirium
  • cerebral convulsions
  • loss of consciousness
  • coma
  • weak respiration
  • bradycardia
  • sweating
  • clammy skin
  • anxiety
  • tachycardia
  • hypertension
  • palpitations
  • angina
  • deep vein thrombosis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture from entering. The storage temperature should ideally be maintained at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Light pink oblong film-coated tablet

Package unit

30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.